Celsius Holdings operates in the energy drink subsegment of the global nonalcoholic beverage market, with 95% of revenue concentrated in North America... Show more
Celsius Holdings (CELH) has solidified its position as a leader in the functional energy drink segment, commanding approximately 20-21% U.S. market share across its portfolio of CELSIUS, Alani Nu, and Rockstar brands. The company's "better-for-you" positioning—emphasizing zero sugar, natural caffeine from green tea, and fitness-oriented branding—differentiates it from traditional high-sugar rivals like Monster Beverage and Red Bull. Strategic distribution via PepsiCo's direct-store-delivery (DSD) network achieves 99.5% all-commodity volume (ACV) reach in North America, enabling rapid shelf space gains projected at 17% for CELSIUS and 102% for Alani Nu in 2026.
Acquisitions of Alani Nu ($1.8B in 2025) and Rockstar have diversified its appeal across demographics, from health-focused females (Alani Nu) to broader youth segments (Rockstar). International foothold in Europe (e.g., #4 in Nordics, launches in Spain/Portugal) and Oceania via Suntory partnerships supports medium-term growth, though North America remains ~95% of revenue. Competitive moats include innovation in hydration lines and marketing tie-ups (e.g., Formula One with Aston Martin), but scaling margins amid integration challenges will test structural advantages.
Upcoming quarterly earnings, expected August 2026, will spotlight margin roadmap and international velocity post-Q1 2026's record $783M revenue (138% YoY). Product integrations like Alani Nu's PepsiCo DSD shift (Dec 2025) and Rockstar's full H1 2026 rollout promise accelerated velocity in convenience channels.
Geographic catalysts include Spain launch (Suntory, March 2026) and Portugal expansion, building on 55% international revenue growth in Q1. Partnerships like Aston Martin F1 and Palm Tree Festival enhance brand visibility. Analyst activity remains robust: post-Q1, JPMorgan raised target to $70, UBS held Buy, while some like Morgan Stanley trimmed to $55 amid margin scrutiny—yet consensus holds "Moderate Buy" with ~$64 average target (high $90, low $41). Positive surprises in guidance or upgrades could boost sentiment, as targets imply 80-100% upside.
The energy drinks market, valued at ~$77-83B globally in 2026, grows at 7-8% CAGR through 2030-34, fueled by functional demand for low-sugar, cognitive-enhancing beverages amid wellness trends. U.S. segment (~$21B) expands 4-8% on Gen Z/Millennial adoption for focus and recovery, favoring CELH's nootropics/electrolytes profile over sugary incumbents.
Macro headwinds include inflation squeezing premium pricing (consumers 40% likely to cut back on hikes) and interest rates curbing discretionary spend. Geopolitical commodity volatility (aluminum cans) pressures costs, though CELH's PepsiCo scale aids mitigation. Regulatory scrutiny on caffeine/sugar claims heightens, but "clean label" shift benefits zero-sugar leaders. Consumer cycles toward hydration/functionals align with fitness rebound, though recessions could pivot demand to value options.
Tickeron’s Trend Prediction Engine is an AI-powered forecasting tool that helps traders identify whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. It leverages advanced machine learning algorithms to analyze historical price patterns, volume data, and technical indicators, spotting developing trends, evaluating possible breakouts or reversals, and providing predictions across a wide range of tradable instruments. The tool includes searchable prediction categories by timeframe, historical accuracy context for backtested performance, and alert functionality to notify users of high-confidence signals. Designed for both novice and experienced investors, it empowers data-driven decisions amid market volatility. Explore the Trend Prediction Engine today to enhance your trading strategy.
2026 guidance emphasizes margin expansion to low-50% gross margins (Q2 flat, H2 improvements) via portfolio synergies and scale. Consensus forecasts ~$3.35B revenue (33% growth) and EPS $1.62, with 2027 at $3.68B/$2.03, reflecting sustained 20%+ top-line trajectory on 9-10% industry growth.
Structural drivers include international scaling (target 10%+ of revenue), shelf expansions, and innovations like CELSIUS Hydration powders. Cost evolution via PepsiCo efficiencies supports ROE ~15% long-term. Tech transitions to nootropics/adaptogens counter competitive threats from incumbents' copycats. Regulatory focus on clean ingredients favors CELH, while capital priorities lean buybacks/dividends amid cash generation. Analyst expectations, with "Strong Buy" skew and $62+ targets, hinge on execution; outperformance in Europe/Asia could reshape sentiment positively.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
a company which engages in development, marketing of beverages
Industry BeveragesNonAlcoholic
A.I.dvisor indicates that over the last year, CELH has been loosely correlated with PRMB. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CELH jumps, then PRMB could also see price increases.
| Ticker / NAME | Correlation To CELH | 1D Price Change % | ||
|---|---|---|---|---|
| CELH | 100% | +2.75% | ||
| PRMB - CELH | 49% Loosely correlated | +2.59% | ||
| MNST - CELH | 25% Poorly correlated | +0.87% | ||
| KDP - CELH | 24% Poorly correlated | +1.54% | ||
| FIZZ - CELH | 22% Poorly correlated | -0.05% | ||
| CCEP - CELH | 21% Poorly correlated | +1.69% | ||
More | ||||
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CELH's RSI Indicator exited the oversold zone, of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for CELH just turned positive on June 12, 2026. Looking at past instances where CELH's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CELH advanced for three days, in of 311 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved below the 0 level on June 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CELH as a result. In of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CELH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
CELH broke above its upper Bollinger Band on May 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for CELH entered a downward trend on June 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CELH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.963) is normal, around the industry mean (7.916). P/E Ratio (67.860) is within average values for comparable stocks, (45.556). Projected Growth (PEG Ratio) (0.309) is also within normal values, averaging (5.180). CELH's Dividend Yield (0.000) is considerably lower than the industry average of (0.026). P/S Ratio (2.561) is also within normal values, averaging (3.329).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CELH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 71, placing this stock worse than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.